Tech Company Financing Transactions
Neuronetics Funding Round
Neuronetics closed a $15 million financing round on 6/7/2017. Backers included Ascension Ventures, Accuitive Medical Ventures and GE Ventures.
Transaction Overview
Company Name
Announced On
6/7/2017
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
We are excited to support the management team of Neuronetics and believe accelerating the market adoption of NeuroStar Advanced Therapy is the right choice for patients and clinicians.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3222 Phoenixville Pike
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Sullivan
Chief Financial Officer
Peter Donato
Chief Financial Officer
Steve Furlong
VP - Bus. Development
Daniel Guthrie
VP - Bus. Development
Anthony Pui
VP - General Counsel
Andrew Macan
VP - Product Management
Greg Harper
Browse more venture capital transactions:
Prev: 6/7/2017: Armis venture capital transaction
Next: 6/7/2017: Savonix venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs